Document 0297 DOCN M9460297 TI Alternative modes of polymerization distinguish the subunits of equine infectious anemia virus reverse transcriptase. DT 9404 AU Wohrl BM; Howard KJ; Jacques PS; Le Grice SF; Division of Infectious Diseases, Case Western Reserve University; School of Medicine, Cleveland, Ohio 44106. SO J Biol Chem. 1994 Mar 18;269(11):8541-8. Unique Identifier : AIDSLINE MED/94179245 AB A comparative study of recombinant 51- and 66-kDa subunits comprising equine infectious anemia virus reverse transcriptase (EIAV RT) is reported. Both polypeptides sedimented as stable homodimers (molecular mass, 102 and 132 kDa, respectively) when analyzed by rate sedimentation through glycerol gradients. Consistent with their dimer composition, each preparation displayed considerable levels of both RNA- and DNA-dependent DNA polymerase activity on different homopolymeric template/primer combinations. However, a detailed analysis of the polymerization products indicated qualitative differences. Whereas p66 EIAV RT proceeded essentially unimpaired along both RNA and DNA templates, p51-catalyzed DNA synthesis was interrupted close to or in the immediate vicinity of the primer. A series of programmed 2-step polymerization reactions suggests that p51 EIAV RT enters an abortive mode of polymerization. Duplication of this observation with p51 human immunodeficiency virus-1 RT, together with recent observations from murine RT, suggests that lack of a ribonuclease H domain and loss of contact with the nascent product from the polymerase active center have profound consequences on the mode of polymerization. DE Base Sequence Comparative Study DNA Polymerases/*METABOLISM DNA Primers Electrophoresis, Polyacrylamide Gel Human Infectious Anemia Virus, Equine/*ENZYMOLOGY Macromolecular Systems Molecular Sequence Data Molecular Weight Recombinant Proteins/CHEMISTRY/METABOLISM Reverse Transcriptase/*CHEMISTRY/ISOLATION & PURIF/*METABOLISM Substrate Specificity Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. Templates JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).